SecBot SecBot
SECBOTREPLAY Home › Report › BSX

BSX · A cluster of insider buying at Boston Scientific, led by CEO Michael…

BOSTON SCIENTIFIC CORP · CLUSTER filed Aug 7, 2026 at 16:16 ET

At the news

MIXEDIMPACT 5/10

CLUSTER filed Aug 7, 2026 at 16:16 ET

A cluster of insider buying at Boston Scientific, led by CEO Michael Mahoney's $9.0M open-market purchase, follows the company's Q2 2026 earnings beat but significantly lowered full-year guidance. The buying is concentrated in the days after the earnings release, suggesting insiders view the post-guidance-cut stock price as undervalued. The total insider buying of $9.33M represents a negligible ~0.013% of the $71.4B market cap, but the CEO's personal $9M purchase is a strong conviction signal that partially offsets the bearish earnings context.

  • CEO Michael Mahoney purchased 186,240 shares for $9.0M in an open-market transaction on 2026-08-03.
  • Total insider buying cluster of $9.33M from 3 insiders over a 7-day window.
  • Director David Habiger made three small open-market purchases totaling ~$157K.
  • The buying follows a Q2 2026 earnings beat (EPS $0.86 vs. $0.83 consensus) but a significant guidance cut (organic growth to 5-6% from 6.5-8%, EPS to $3.28-$3.32 from $3.34-$3.41).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access